Haemostasis in relation to dietary fat as estimated by erythrocyte fatty acid composition: The prime study

Thrombosis Research

Volumn 102, Issue 4, 2001, Pages 285-293

  Scarabin, P Y ^a   Aillaud, M F ^b   Luc, G ^a,c   Lacroix, B ^c   Mennen, L ^a   Amouyel, P ^a   Evans, A ^d   Ferrieres J ^a   Arveiler, D ^e   Juhan Vague, I ^b  

^a INSERM   (France)

^b TIMONE HOSPITAL   (France)

^c UNIV LILLE   (France)

^d Belfast MONICA Project   (United Kingdom)

^e MONICA Project   (France)

Author keywords

Dietary fat; Fatty acids; Haemostasis

Indexed keywords

ANTIGEN; ARACHIDIC ACID; BLOOD CLOTTING FACTOR 7; D DIMER; FATTY ACID; FIBRINOGEN; FISH OIL; PHOSPHOLIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGE; ARTICLE; BODY MASS; EPIDEMIOLOGICAL DATA; ERYTHROCYTE; FAT INTAKE; GAS CHROMATOGRAPHY; HEMOSTASIS; HUMAN; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; DIETARY FATS; ERYTHROCYTES; FACTOR VII; FATTY ACIDS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMOKING; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 0035874023     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00245-6     Document Type: Article

References (48)

1. Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller GJ, North WRS, Stirling Y, Thompson SG Haemostatic function and ischaemic heart disease: prinicpal results of the Northwick Park Heart Study. Lancet. 2:1986;533-537.
2. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehad PJ, Elwood PC Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation. 83:1991;836-844.
3. Hamsten A, Walldius G, Szamosi A, Blombäck M, de Faire U, Dahlen G, Landou C, Wiman B Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1:1987;3-8.
4. Thompson SG, Kienast MAJ, Pyke SDM, Haverkate F, van de Loo JCW Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 332:1995;635-641.
5. Lowe GDO, Yarnell JWG, Sweetnam PM, Rumley A, Thomas HF, Elwood PC Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischemic heart disease in the Caerphilly Study. Thromb Haemostasis. 79:1998;129-133.
6. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 341:1993;1165-1168.
7. Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation. 94:1996;2057-2063.
8. Margaglione M, Cappucci G, d'Addedda M, Colaizzo D, Giuliani N, Vecchione G, Mascolo G, Grandone E, Di Minno G PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis. Relation to environmental and genetic determinants. Arterioscler, Thromb, Vasc Biol. 18:1998;562-567.
9. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 91:1991;191-205.
10. de Pergola G, de Mitrio V, Giorgino F, Sciaraffia M, Minenna A, Di Bari L, Pannacciulli N, Giorgino R Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution. Int J Obes. 21:1997;527-535.
11. DeSouza CA, Parker Jones P, Seals DR Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women. Arteriocler, Thromb, Vasc Biol. 18:1998;362-368.
12. Pearson TA, LaCava J, Weil HFC Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease. Am J Clin Nutr. 65:1997;1674S-1682S. Supplement.
13. Blann AD, Dobrotova M, Kubisz P, McCollum CN von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemostasis. 74:1995;626-630.
14. Miller GJ Lipoproteins and thrombosis: effects of lipid lowering. Curr Opin Lipidol. 6:1995;38-42.
15. Scarabin PY, Aillaud MF, Amouyel P, Evans A, Luc G, Ferrières J, Arveiler D, Juhan-Vague I Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10.5000 male participants in a prospective study of myocardial infarction. Thromb Haemostasis. 80:1998;749-756.
16. Mennen LI, Schouten EG, Grobbee DE, Kluft C Coagulation factor VII, dietary fat and blood lipids: a review. Thromb Haemostasis. 76:1996;492-499.
17. Hwang DH, Schanmugam PS, Ruan DH, Boudreau MD, Windhouser MM, Tulley RT, Brooks ER, Bray GA Does vegetable oil attenuate the benficial effects of fish oil in reducing risk factors for cardiovascular disease? Am J Clin Nutr. 66:1997;89-96.
18. Schmidt EB, Nielsen LK, Pedersen JO, Kornerup HJ, Dyerberg J The effect of n-3 polyunsaturated fatty acids on lipids, platelet function, coagulation, fibrinolysis and monocyte chemotaxis in patients with hypertension. Clin Chim Acta. 189:1990;25-32.
19. Toft I, Bonaa KH, Ìngebretsen O, Nordoy A, Jenssen T Fibrinolytic function after dietary supplementation with omega-3 polyunsaturated fatty acids. Arterioscler, Thromb, Vasc Biol. 17:1997;814-819.
20. Lopez-Segura F, Velasco F, Lopez-Miranda J, Castro P, Lopez-Pedrera R, Blanco AL, Jimenez-Pereperez J, Torres A, Trjillo J, Ordovas JM, Pérez-Jiménez F Monounsaturated fatty acid-enriched diet decreases plasma plasminogen activator inhibitor type 1. Arterioscler, Thromb, Vasc Biol. 16:1996;82-88.
21. Dunstan DW, Mori TA, Puddey IB, Beilin L, Burke V, Morton AR, Stanton KG A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics. Thromb Haemostasis. 81:1999;367-372.
22. Hellsten G, Boman K, Saarem K, Hallmans G, Nilsson TK Effects on fibrinolytic activity of corn oil and a fish oil preparation enriched with omega-3-polyunsaturated fatty acids in a long-term study. Curr Med Res Opin. 13:1993;133-139.
23. Marckmann P, Sandström B, Jespersen J Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in dietary fat content. Arterioscler Thromb. 12:1992;201-205.
24. Sanders TAB, Oakley FR, Miller GJ, Mitropoulos KA, Crook D, Oliver MF Influence of n-6 versus n-3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors. Arterioscler, Thromb, Vasc Biol. 17:1997;3449-3460.
25. Takimoto G, Galang J, Lee GK, Bradlow BA Plasma fibrinolytic activity after ingestion of omega-3 fatty acids in human subjects. Thromb Res. 54:1989;573-582.
26. Marckmann P, Bladbjerg EM, Jespersen J Dietary fish oil (4 g daily) and cardiovascular risk markers in healthy men. Arterioscler, Thromb, Vasc Biol. 17:1997;3384-3391.
27. Allman-Farinelli MA, Hall D, Kingham K, Pang D, Petocz P, Favaloro EJ Comparison of the effects of two low fat diets with different alpha-linolenic-linoleic acid ratios on coagulation and fibrinolysis. Atherosclerosis. 142:1999;159-168.
28. Muller AD, van Houwelingen AC, van Dam-Mieras MCE, Bas BM, Hornstra G Effect of a moderate fish intake on haemostatic parameters in healthy males. Thromb Haemostasis. 61:1989;468-473.
29. Archer SL, Green D, Chamberlain M, Dyer AR, Liu K Association of dietary fish and n-3 fatty acid intake with hemostatic factors in the coronary artery risk development in young adults (CARDIA) study. Arterioscler, Thromb, Vasc Biol. 18:1998;1119-1123.
30. Rasmussen O, Thomsen C, Ingerslev J, Hermansen K Decrease in von Willebrand factor levels after a high-monounsaturated-fat diet in non-insulin-dependent diabetic subjects. Metabolism. 43:1994;1406-1409.
31. Almendingen K, Seljeflot I, Sandstad B, Pedersen JI Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on hemostatic variables in men. Arterioscler, Thromb, Vasc Biol. 16:1996;375-380.
32. Ma JM, Folsom AR, Shahar E, Eckfeldt JH Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. Am J Clin Nutr. 62:1995;564-571.
33. Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res. 38:1997;2012-2022.
34. The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Q J Med. 91:1998;667-676.
35. Clauss A Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol. 17:1957;237-246.
36. Brozovic M, Stirling Y, Harricks C Factor VII in an industrial population. Br J Haematol. 28:1974;381-391.
37. Cigolini M, Targher G, Seidell JC, Schiavon R, Manara F, Zenti MG, Mattioli C, De Sandre G Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men. Ahterosclerosis. 106:1994;139-147.
38. Romon M, Nuttents MC, Theret N, Delbart C, Lecerf JM, Fruchart JC, Salomez JL Comparison between fat intake assessed by a 3-day food record and phospholipid fatty acid composition of red blood cells: results from the Monitoring of Cardiovascular Disease-Lille Study. Metabolism. 44:1995;1139-1145.
39. Vidgren HM, Agren JJ, Schwab U, Rissanen T, Hanninen O, Uusitupa MI Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary suppelementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids. 32:1997;697-705.
40. Folsom AR, Ma J, Eckfeldt JH, Shahar E, Wu KK Plasma phospholipid fatty acid composition and factor VII coagulant activity. Atherosclerosis. 111:1994;199-207.
41. Salomaa VV, Salminen I, Rasi V, Vahtera E, Aro A, Myllylä G Association of the fatty acid composition of serum phospholipids with hemostatic factors. Arterioscler, Thromb, Vasc Biol. 17:1997;809-813.
42. Cigolini M, Targher G, de Sandr G, Muggeo M, Seidell JC Plasma fibrinogen in relation to serum insulin, smoking habits and adipose tissue fatty acids in healthy men. Eur J Clin Invest. 24:1994;126-130.
43. Marckmann P, Jespersen J, Leth T, Sandström B Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. J Int Med. 229:1991;317-323.
44. Elwood PC, Beswick AD, O'Brien JR, Yarnell JWG, Layzell JC, Limb ES Inter-relationships between haemostatic tests and the effects of some dietary determinants in the Caerphilly cohort of older men. Blood Coagulation Fibrinolysis. 4:1993;529-536.
45. Lip GYH, Lowe GDO Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci. 89:1995;205-214.
46. Kromhout D, Bosschieter EB, deCoulander CL The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 312:1985;1205-1209.
47. Juhan-Vague I, Thompson SG, Jespersen J Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. Arterioscler Thromb. 13:1993;1865-1873.
48. Blann AD, Lip GYH Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus. Diab Med. 15:1998;634-642.